DOD Biotech PCL (BKK:DOD) COGS-to-Revenue : 0.65 (As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is DOD Biotech PCL COGS-to-Revenue?

DOD Biotech PCL's Cost of Goods Sold for the three months ended in Mar. 2025 was ฿111.9 Mil. Its Revenue for the three months ended in Mar. 2025 was ฿171.1 Mil.

DOD Biotech PCL's COGS to Revenue for the three months ended in Mar. 2025 was 0.65.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. DOD Biotech PCL's Gross Margin % for the three months ended in Mar. 2025 was 34.57%.

DOD Biotech PCL COGS-to-Revenue Historical Data

The historical data trend for DOD Biotech PCL's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DOD Biotech PCL COGS-to-Revenue Chart

DOD Biotech PCL Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

COGS-to-Revenue

Get a 7-Day Free Trial

0.57

0.74

0.61

0.68

DOD Biotech PCL Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
COGS-to-Revenue	Get a 7-Day Free Trial															0.64	0.90	0.61	0.69	0.65

DOD Biotech PCL COGS-to-Revenue Calculation

DOD Biotech PCL's COGS to Revenue for the fiscal year that ended in Dec. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	438.577	/	645.385
	=	0.68

DOD Biotech PCL's COGS to Revenue for the quarter that ended in Mar. 2025 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	111.925	/	171.066
	=	0.65

DOD Biotech PCL (BKK:DOD) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

DOD Biotech PCL's Gross Margin % for the three months ended in Mar. 2025 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	111.925 / 171.066
	=	34.57 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

DOD Biotech PCL COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of DOD Biotech PCL's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

DOD Biotech PCL Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » DOD Biotech PCL (BKK:DOD) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

DOD-R:Thailand

Address

No. 111, Moo 2, Tumbol Taa jeen, Amphor Muengsamutsakhon, Samut Sakhon, THA, 74000

Website

https://www.dodbiotech.com

DOD Biotech PCL is principally engaged in the manufacture and distribution of food supplements and health drinks of all kinds. The company is organized into business units based on its products and services and has reportable segments as; Supplementary business, Manufacturing cosmetic business, Manufacturing extraction business, and others. A majority of its revenue is generated from the Supplementary business which manufactures and sells dietary supplements in the form of capsules, tablets, soft gels, gummies, probiotics, shot drinks, and others. Geographically, the company operates only in Thailand.

DOD Biotech PCL Headlines

No Headlines